[go: up one dir, main page]

DE3773128D1 - Cyclopentanaether, ihre herstellung und pharmazeutische formulierung. - Google Patents

Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.

Info

Publication number
DE3773128D1
DE3773128D1 DE8787309317T DE3773128T DE3773128D1 DE 3773128 D1 DE3773128 D1 DE 3773128D1 DE 8787309317 T DE8787309317 T DE 8787309317T DE 3773128 T DE3773128 T DE 3773128T DE 3773128 D1 DE3773128 D1 DE 3773128D1
Authority
DE
Germany
Prior art keywords
cyclopentanaether
production
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787309317T
Other languages
English (en)
Inventor
Eric W Collington
Harry Finch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE3773128D1 publication Critical patent/DE3773128D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE8787309317T 1986-10-22 1987-10-21 Cyclopentanaether, ihre herstellung und pharmazeutische formulierung. Expired - Fee Related DE3773128D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868625321A GB8625321D0 (en) 1986-10-22 1986-10-22 Chemical compounds

Publications (1)

Publication Number Publication Date
DE3773128D1 true DE3773128D1 (de) 1991-10-24

Family

ID=10606149

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787309317T Expired - Fee Related DE3773128D1 (de) 1986-10-22 1987-10-21 Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.

Country Status (5)

Country Link
US (1) US4851523A (de)
EP (1) EP0268389B1 (de)
JP (1) JPS63122663A (de)
DE (1) DE3773128D1 (de)
GB (1) GB8625321D0 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1709699A (en) * 1997-12-22 1999-07-12 Alcon Laboratories, Inc. 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4942648A (de) * 1972-08-24 1974-04-22
US4304926A (en) * 1974-08-14 1981-12-08 The Upjohn Company Phenacyl-type esters of PGE-types compounds
US3979440A (en) * 1974-08-14 1976-09-07 The Upjohn Company Phenacyl-type esters of phenyl-substituted PGE-type compounds
US4178457A (en) * 1978-07-10 1979-12-11 Syntex (U.S.A.) Inc. (dl)-16-Phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives and processes for the production thereof
GB8510277D0 (en) * 1985-04-23 1985-05-30 Glaxo Group Ltd Carbocyclic compounds
GB8410396D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Carbocyclic compounds

Also Published As

Publication number Publication date
JPS63122663A (ja) 1988-05-26
EP0268389A2 (de) 1988-05-25
EP0268389B1 (de) 1991-09-18
GB8625321D0 (en) 1986-11-26
EP0268389A3 (en) 1988-09-21
US4851523A (en) 1989-07-25

Similar Documents

Publication Publication Date Title
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE111452T1 (de) Tetrahydronaphthalin- und indanderivate, deren herstellung und verwendung für pharmazeutische präparate.
ATE37028T1 (de) Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte.
DE69011059D1 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE3750431D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
DE3877406D1 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
DE3885534D1 (de) Arylphosphorderivate, ihre Herstellung und Verwendung.
DE3679920D1 (de) Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE3773722D1 (de) Inosose-derivate und ihre herstellung.
DE3776620D1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.
EP0672052A1 (de) Tachyquinin antagonisten, ihre herstellung und ihre verwendung in pharmazeutischen formulierungen.
DE3784046D1 (de) Pulverfoermige emulgiermittelzubereitung, ihre herstellung und verwendung.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE3681856D1 (de) Pharmazeutische 2-oxopyrrolidinverbindungen, ihre salze und ihre herstellung.
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.
DE3786927D1 (de) Antithrombotische arzneimittel und deren herstellung.
DE3774849D1 (de) Alkylaminoalkylisch oder heterocyclylalkylisch an den triazolring substituierte 8-azaxanthine, ihre physiologisch vertraeglichen salze, ihre pharmazeutische zubereitungen mit antibronchospastischer wirkung und verfahren zu ihrer herstellung.
DE3773128D1 (de) Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.
DE3764233D1 (de) Cyclopentylaether, deren herstellung und pharmazeutische formulierung.
DE3779525D1 (de) 5-aminomethyl-2-oxazolidinon-derivate, ihre herstellung und ihre anwendung in der heilkunde.
DE3677319D1 (de) Pharmazeutische 1,4-dihydropyridinderivate, ihre salze und herstellung.
DE3670083D1 (de) Pharmazeutische pyrrolizidinverbindungen und -zusammensetzungen und ihre herstellung.
DE3761379D1 (de) 1,3-propandiaminderivate, ihre herstellung und sie enthaltende arzneimittel.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
DE3767084D1 (de) Dipropargyloxybenzolverbindungen und ihre herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee